Bellerophon Therapeutics (NASDAQ:BLPH) Shares Pass Below 200 Day Moving Average – What’s Next?

by · The Cerbat Gem

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.04 and traded as low as $0.01. Bellerophon Therapeutics shares last traded at $0.01, with a volume of 7,027 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Bellerophon Therapeutics in a research report on Thursday. They set a “hold” rating for the company.

Get Our Latest Report on Bellerophon Therapeutics

Bellerophon Therapeutics Trading Down 25.5 %

The company has a market capitalization of $146,796.00, a P/E ratio of -0.01 and a beta of 0.74. The company’s fifty day moving average is $0.03 and its 200 day moving average is $0.04.

Bellerophon Therapeutics Dividend Announcement

The business also recently declared a dividend, which was paid on Wednesday, December 18th. Stockholders of record on Friday, December 20th were issued a $0.019 dividend. This represents a dividend yield of 117.8%. The ex-dividend date of this dividend was Thursday, December 19th.

About Bellerophon Therapeutics

(Get Free Report)

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.

Further Reading